June 13, 2018
Rose
Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home. Using motion capture technology based on the Microsoft Kinect, the Go engages patients with a range of activities set in displayed 3D environments that promote motor and task functions.
from MobiHealthNews https://ift.tt/2sT552j
June 13, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Finnish patient monitoring platform closes $5.4M funding round- Study: App accurately tracks Parkinson's disease symptoms
- JPMorgan CEO shares more on aims, tactics of healthcare venture with Amazon, Berkshire Hathaway
- Outcome Health will pay $2.9M in class-action settlement about 'daily nutrition tip' texts
- Apple faces new lawsuit over its heart rate monitor
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment